BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chappell WH, Candido S, Abrams SL, Russo S, Ove R, Martelli AM, Cocco L, Ramazzotti G, Cervello M, Montalto G, Steelman LS, Leng X, Arlinghaus RB, Libra M, Mccubrey JA. Roles of p53, NF-κB and the androgen receptor in controlling NGAL expression in prostate cancer cell lines. Advances in Biological Regulation 2018;69:43-62. [DOI: 10.1016/j.jbior.2018.05.002] [Cited by in Crossref: 12] [Cited by in F6Publishing: 19] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Resurreccion EP, Fong K. The Integration of Metabolomics with Other Omics: Insights into Understanding Prostate Cancer. Metabolites 2022;12:488. [DOI: 10.3390/metabo12060488] [Reference Citation Analysis]
2 Alzaim I, Al-saidi A, Hammoud SH, Darwiche N, Al-dhaheri Y, Eid AH, El-yazbi AF. Thromboinflammatory Processes at the Nexus of Metabolic Dysfunction and Prostate Cancer: The Emerging Role of Periprostatic Adipose Tissue. Cancers 2022;14:1679. [DOI: 10.3390/cancers14071679] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Schröder SK, Pinoé-schmidt M, Weiskirchen R. Lipocalin-2 (LCN2) Deficiency Leads to Cellular Changes in Highly Metastatic Human Prostate Cancer Cell Line PC-3. Cells 2022;11:260. [DOI: 10.3390/cells11020260] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Li Y, Zhang J, Xu J, Liu S. The Metabolism Symbiosis Between Pancreatic Cancer and Tumor Microenvironment. Front Oncol 2021;11:759376. [PMID: 34976805 DOI: 10.3389/fonc.2021.759376] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
5 Crescenzi E, Leonardi A, Pacifico F. NGAL as a Potential Target in Tumor Microenvironment. Int J Mol Sci 2021;22:12333. [PMID: 34830212 DOI: 10.3390/ijms222212333] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
6 Yuan JH, Xie LS, Zhu YH, Wang XH, Zhang YJ, Wang XJ. Combination of neutrophil gelatinase-associated lipocalin and matrix metalloproteinase-9 are biomarkers for the detection of colon tubular adenocarcinoma . World J Gastrointest Oncol 2021; 13(10): 1506-1517 [PMID: 34721781 DOI: 10.4251/wjgo.v13.i10.1506] [Reference Citation Analysis]
7 Cheng H, Tang S, Lian X, Meng H, Gu X, Jiang J, Li X. The Differential Antitumor Activity of 5-Aza-2'-deoxycytidine in Prostate Cancer DU145, 22RV1, and LNCaP Cells. J Cancer 2021;12:5593-604. [PMID: 34405020 DOI: 10.7150/jca.56709] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
8 Hsu CY, Lin YS, Weng WC, Panny L, Chen HL, Tung MC, Ou YC, Lin CC, Yang CH. Phloretin Ameliorates Testosterone-Induced Benign Prostatic Hyperplasia in Rats by Regulating the Inflammatory Response, Oxidative Stress and Apoptosis. Life (Basel) 2021;11:743. [PMID: 34440487 DOI: 10.3390/life11080743] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
9 Abrams SL, Akula SM, Martelli AM, Cocco L, Ratti S, Libra M, Candido S, Montalto G, Cervello M, Gizak A, Rakus D, Steelman LS, McCubrey JA. Sensitivity of pancreatic cancer cells to chemotherapeutic drugs, signal transduction inhibitors and nutraceuticals can be regulated by WT-TP53. Adv Biol Regul 2021;79:100780. [PMID: 33451973 DOI: 10.1016/j.jbior.2020.100780] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
10 Chung WC, Zhou X, Atfi A, Xu K. PIK3CG Is a Potential Therapeutic Target in Androgen Receptor-Indifferent Metastatic Prostate Cancer. Am J Pathol 2020;190:2194-202. [PMID: 32805234 DOI: 10.1016/j.ajpath.2020.07.013] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
11 Schröder SK, Asimakopoulou A, Tillmann S, Koschmieder S, Weiskirchen R. TNF-α controls Lipocalin-2 expression in PC-3 prostate cancer cells. Cytokine 2020;135:155214. [PMID: 32712458 DOI: 10.1016/j.cyto.2020.155214] [Cited by in Crossref: 4] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
12 Chappell WH, Candido S, Abrams SL, Akula SM, Steelman LS, Martelli AM, Ratti S, Cocco L, Cervello M, Montalto G, Nicoletti F, Libra M, McCubrey JA. Influences of TP53 and the anti-aging DDR1 receptor in controlling Raf/MEK/ERK and PI3K/Akt expression and chemotherapeutic drug sensitivity in prostate cancer cell lines. Aging (Albany NY) 2020;12:10194-210. [PMID: 32492656 DOI: 10.18632/aging.103377] [Cited by in Crossref: 6] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
13 Braglia L, Zavatti M, Vinceti M, Martelli AM, Marmiroli S. Deregulated PTEN/PI3K/AKT/mTOR signaling in prostate cancer: Still a potential druggable target? Biochim Biophys Acta Mol Cell Res 2020;1867:118731. [PMID: 32360668 DOI: 10.1016/j.bbamcr.2020.118731] [Cited by in Crossref: 13] [Cited by in F6Publishing: 30] [Article Influence: 6.5] [Reference Citation Analysis]
14 Akula SM, Candido S, Abrams SL, Steelman LS, Lertpiriyapong K, Cocco L, Ramazzotti G, Ratti S, Follo MY, Martelli AM, Murata RM, Rosalen PL, Bueno-silva B, Matias de Alencar S, Falasca M, Montalto G, Cervello M, Notarbartolo M, Gizak A, Rakus D, Libra M, Mccubrey JA. Abilities of β-Estradiol to interact with chemotherapeutic drugs, signal transduction inhibitors and nutraceuticals and alter the proliferation of pancreatic cancer cells. Advances in Biological Regulation 2020;75:100672. [DOI: 10.1016/j.jbior.2019.100672] [Cited by in Crossref: 2] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
15 Faria DK, Faria CS, Doi D, Acencio MMP, Antonangelo L. Hybrid panel of biomarkers can be useful in the diagnosis of pleural and peritoneal effusions. Clin Chim Acta 2019;497:48-53. [PMID: 31310745 DOI: 10.1016/j.cca.2019.07.015] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
16 Cao Z, Xu L, Zhao S. Exosome-derived miR-27a produced by PSC-27 cells contributes to prostate cancer chemoresistance through p53. Biochemical and Biophysical Research Communications 2019;515:345-51. [DOI: 10.1016/j.bbrc.2019.05.120] [Cited by in Crossref: 14] [Cited by in F6Publishing: 22] [Article Influence: 4.7] [Reference Citation Analysis]
17 Liao N, Shih Y, Chou J, Chen K, Chen Y, Lee M, Peng S, Leu S, Chung J. Cardamonin Induces Cell Cycle Arrest, Apoptosis and Alters Apoptosis Associated Gene Expression in WEHI-3 Mouse Leukemia Cells. Am J Chin Med 2019;47:635-56. [DOI: 10.1142/s0192415x19500332] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
18 Pfeifhofer-Obermair C, Tymoszuk P, Petzer V, Weiss G, Nairz M. Iron in the Tumor Microenvironment-Connecting the Dots. Front Oncol 2018;8:549. [PMID: 30534534 DOI: 10.3389/fonc.2018.00549] [Cited by in Crossref: 44] [Cited by in F6Publishing: 63] [Article Influence: 11.0] [Reference Citation Analysis]
19 Abrams SL, Lertpiriyapong K, Yang LV, Martelli AM, Cocco L, Ratti S, Falasca M, Murata RM, Rosalen PL, Lombardi P, Libra M, Candido S, Montalto G, Cervello M, Steelman LS, Mccubrey JA. Introduction of WT-TP53 into pancreatic cancer cells alters sensitivity to chemotherapeutic drugs, targeted therapeutics and nutraceuticals. Advances in Biological Regulation 2018;69:16-34. [DOI: 10.1016/j.jbior.2018.06.002] [Cited by in Crossref: 12] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]